Medical device company Boston Scientific (NYSE:BSX) reported in Q1 CY2025, with sales up 20.9% year on year to $4.66 billion.

Boston Scientific raised its annual profit forecast after strong sales of its heart devices helped beat Wall Street expectations for first-quarter profit. Shares of the medical device maker soared ...

Shares of medical device company Boston Scientific (NYSE:BSX) jumped 8.5% in the pre-market session after the company ...

Boston Scientific (NYSE: BSX) today announced positive 12-month study results for its Farapulse pulsed field ablation (PFA) ...

Medical device company Boston Scientific (NYSE:BSX) will be reporting results tomorrow before market open. Here’s what to ...

After having served as CFO of Boston Scientific since 2014, Brennan will retire from his executive leadership roles at the ...

Boston Scientific topped Q1 revenue and EPS forecasts, lifted its 2025 outlook, and announced CFO Dan Brennan's retirement ...

Anumana announced that it brought its diagnostic ECG-AI technology into perioperative and acute cardiac care with Boston ...

The company joins Johnson & Johnson and Abbott as top medtech firms that expect an impact in the hundreds of millions of ...

Boston Scientific said that while tariffs pose “unfortunate” headwinds—which are poised to add about $200 million to the cost ...

For the current quarter ending in June, Boston Scientific expects its per-share earnings to range from 71 cents to 73 cents. The company expects full-year earnings in the range of $2.87 to $2.94 per ...

Atalys specializes in high-precision tooling, advanced plastics processing and custom automated assembly for critical medical ...